Upregulation of Interleukin 8 by Oxygen-deprived Cells in Glioblastoma Suggests a Role in Leukocyte Activation, Chemotaxis, and Angiogenesis
暂无分享,去创建一个
[1] Mirna Tenan,et al. Fas Ligand Expression in Glioblastoma Cell Lines and Primary Astrocytic Brain Tumors , 1997, Brain pathology.
[2] Erwin G. Van Meir,et al. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? , 1997, The Journal of clinical investigation.
[3] T. Williams,et al. Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. , 1997, Journal of immunology.
[4] M. Elkjaer,et al. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. , 1997, Blood.
[5] Mayumi Ono,et al. Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells , 1996, The Journal of Biological Chemistry.
[6] B. Premack,et al. Chemokine receptors: Gateways to inflammation and infection , 1996, Nature Medicine.
[7] P. Loetscher,et al. The interleukin‐8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells , 1996, European journal of immunology.
[8] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[9] W. Cavenee,et al. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Kiener,et al. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils , 1996, The Journal of experimental medicine.
[11] M. Burdick,et al. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. , 1996, The Journal of clinical investigation.
[12] K. Norrby. Interleukin‐8 and de novo mammalian angiogenesis , 1996, Cell proliferation.
[13] C. Mackay,et al. Expression of monocyte chemoattractant protein‐1 and interleukin‐8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential , 1996, European journal of immunology.
[14] A. Wilks,et al. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. , 1996, Cancer research.
[15] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[16] B. Wolff,et al. Some aspects of IL‐8 pathophysiology III: chemokine interaction with endothelial cells , 1996, Journal of leukocyte biology.
[17] T. Shono,et al. Dual Pathways to Tubular Morphogenesis of Vascular Endothelial Cells by Human Glioma Cells: Vascular Endothelial Growth Factor/Basic Fibroblast Growth Factor and Interleukin‐8 , 1995, Japanese journal of cancer research : Gann.
[18] Armen B. Shanafelt,et al. The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.
[19] K. Plate,et al. Angiogenesis in malignant gliomas , 1995, Glia.
[20] Erwin G. Van Meir. Cytokines and tumors of the central nervous system , 1995, Glia.
[21] C. Tournamille,et al. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy–negative individuals , 1995, Nature Genetics.
[22] R. Horuk,et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor , 1995, The Journal of experimental medicine.
[23] H. Flad,et al. IL-8 specifically binds to endothelial but not to smooth muscle cells. , 1995, Journal of immunology.
[24] R. Ransohoff,et al. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. , 1995, Journal of immunology.
[25] M. Neeman,et al. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] T. Terao,et al. Inactivation of interleukin‐8 by aminopeptidase N (CD13) , 1995, Journal of leukocyte biology.
[27] Erwin G. Van Meir,et al. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells , 1994, Nature Genetics.
[28] D. Williams,et al. Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1. Modulation by antioxidants. , 1994, Journal of immunology.
[29] D. Danilenko,et al. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. , 1994, The Journal of clinical investigation.
[30] R. Horuk,et al. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. , 1994, The Journal of clinical investigation.
[31] Erwin G. Van Meir,et al. Human astrocytomas and glioblastomas express monocyte chemoattractant protein‐1 (MCP‐1) in vivo and in vitro , 1994, International journal of cancer.
[32] C. Bucana,et al. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. , 1994, Cancer research.
[33] J. Kuratsu,et al. Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. , 1994, Journal of neurosurgery.
[34] R. Whyte,et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.
[35] D. Pinsky,et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. , 1994, The Journal of clinical investigation.
[36] A. Ullrich,et al. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.
[37] Erwin G. Van Meir,et al. Analysis of the p53 gene and its expression in human glioblastoma cells. , 1994, Cancer research.
[38] Bing Li,et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.
[39] R. Strieter,et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.
[40] R. Strieter,et al. Interleukin-8. A corneal factor that induces neovascularization. , 1992, The American journal of pathology.
[41] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[42] Georg Breier,et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.
[43] P. Wilkinson,et al. Identification of IL-8 as a locomotor attractant for activated human lymphocytes in mononuclear cell cultures with anti-CD3 or purified protein derivative of Mycobacterium tuberculosis. , 1992, Journal of immunology.
[44] T. Standiford,et al. Anoxia-hyperoxia induces monocyte-derived interleukin-8. , 1992, The Journal of clinical investigation.
[45] Erwin G. Van Meir,et al. Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. , 1992, Cancer research.
[46] P. Murphy,et al. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. , 1991, Science.
[47] W I Wood,et al. Structure and functional expression of a human interleukin-8 receptor. , 1991, Science.
[48] K. Kinzler,et al. Identification of p53 as a sequence-specific DNA-binding protein , 1991, Science.
[49] Erwin G. Van Meir,et al. Human glioblastoma cells release interleukin 6 in vivo and in vitro. , 1990, Cancer research.
[50] M. Hamou,et al. Activation and adhesion molecule expression on lymphoid infiltrates in human glioblastomas , 1990, Journal of Neuroimmunology.
[51] E. Appella,et al. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[52] E. Leonard,et al. Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. , 1990, Journal of immunology.
[53] M. Sticherling,et al. Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8. , 1989, Journal of immunology.
[54] E. Appella,et al. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.
[55] M. Hamou,et al. Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas. , 1988, Cancer research.
[56] H. Handa,et al. Immunohistochemical analysis of infiltrating lymphocytes in central nervous system tumors. , 1986, Neurosurgery.
[57] R. Sutherland,et al. A move for the better. , 1994, Environmental health perspectives.
[58] H. Rodt,et al. Immunofluorescence study of lymphocytic infiltration in gliomas Identification of T-lymphocytes , 1977, Journal of the Neurological Sciences.
[59] J. Folkman,et al. Tumor angiogenesis: a quantitative method for histologic grading. , 1972, Journal of the National Cancer Institute.
[60] 龍頭 正浩. Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells(ヒトグリオーマ細胞における腫瘍壊死因子αによる血管内皮増殖因子の誘導) , 1997 .
[61] J.-M. Bader. Identification of T Lymphocytes , 1997 .
[62] L. Orci,et al. Angiogenesis-regulating cytokines: activities and interactions. , 1996, Current topics in microbiology and immunology.
[63] B. Dewald,et al. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.
[64] W. Pearce,et al. Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cytokines in human aortic aneurysmal blood vessel growth. , 1994, Pathobiology : journal of immunopathology, molecular and cellular biology.
[65] E. Brogi,et al. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. , 1994, Circulation.
[66] K. Bacon,et al. Characterisation of the in vitro responsiveness of lymphocyte subsets to locomotor stimuli by immunocytochemical methods. , 1991, Journal of immunological methods.
[67] M. Haine,et al. Van Damme A. , 1986 .